Bhavyas Pharmaceuticals Private Limited
Manufactures and trades basic chemicals, compounds, and pharmaceuticals since 2019.
2019 | Medak, Telangana (India) | Active
Bhavyas Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.20 Cr
- Paid Up Capital ₹ 2.15 Cr
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.14 Cr
- Revenue Growth 86.29%
- Profit Growth 131.01%
- Ebitda 1100.31%
- Net Worth 2335.97%
- Total Assets 41.64%
About Bhavyas Pharmaceuticals
Bhavyas Pharmaceuticals Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 April 2019 (Six years and one month 7 days old ). Its registered office is in Medak, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.20 Cr and a paid-up capital of Rs 2.15 Cr.
The company currently has active open charges totaling ₹1.14 Cr.
Naresh Ponduri, Anji Nandipati, and Samba Arigela serve as directors at the Company.
Company Details
- Location
Medak, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239TG2019PTC132290
- Company No.
132290
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Bhavyas Pharmaceuticals Private Limited
Explore comprehensive data for Bhavyas Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Bhavyas Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Ponduri  | Director | 25-Apr-2019 | Current |
| Anji Nandipati | Director | 25-Apr-2019 | Current |
| Samba Arigela | Director | 01-Aug-2023 | Current |
Financial Performance of Bhavyas Pharmaceuticals.
Bhavyas Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 86.29% increase. The company also saw a substantial improvement in profitability, with a 131.01% increase in profit. The company's net worth Soared by an impressive increase of 2335.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhavyas Pharmaceuticals?
In 2023, Bhavyas Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹1.14 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 1.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jan 2025 | Others | ₹1.43 M | Open |
| 22 Oct 2024 | Others | ₹1.00 Cr | Open |
How Many Employees Work at Bhavyas Pharmaceuticals?
Bhavyas Pharmaceuticals has a workforce of 8 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhavyas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhavyas Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Bhavyas Pharmaceuticals
Recent activity within the organization
- Charges
A charge with Others amounted to Rs. 0.14 Cr with Charge ID 101033703 was registered on 07 Jan 2025.
- Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 101005750 was registered on 22 Oct 2024.
- Annual General Meeting
Bhavyas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Bhavyas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Director Appointment
Samba Sivarao Arigela was appointed as a Director was appointed as a Director on 01 Aug 2023 & has been associated with this company since 1 year 10 months .
- Director Appointment
Naresh Ponduri was appointed as a Director was appointed as a Director on 25 Apr 2019 & has been associated with this company since 6 years 1 month .
Frequently asked questions
What is the Incorporation or founding date of Bhavyas Pharmaceuticals Private Limited?
Bhavyas Pharmaceuticals Private Limited was incorporated on 25 Apr 2019.
What is authorized share capital and paid-up capital of Bhavyas Pharmaceuticals Private Limited?
The authorized share capital of Bhavyas Pharmaceuticals Private Limited is ₹ 2.20 Cr and paid-up capital is ₹ 2.15 Cr.
Who are the current board members & directors of Bhavyas Pharmaceuticals Private Limited?
Currently 3 directors are associated with Bhavyas Pharmaceuticals Private Limited.
- Naresh Ponduri
- Anji Reddy Nandipati
- Samba Sivarao Arigela
What is the registered address of Bhavyas Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Bhavyas Pharmaceuticals Private Limited is Survey No.367 A/1 367 A/3 Peddagotti Mukkala Village, Sivampet Man Dal India, Medak, Telangana, 502334.
What is the corporate identification number (CIN) and company number of Bhavyas Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Bhavyas Pharmaceuticals Private Limited is U24239TG2019PTC132290 and the company number is 132290 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Bhavyas Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Bhavyas Pharmaceuticals Private Limited has risen by 86.29%.
How many employees does Bhavyas Pharmaceuticals Private Limited currently have?
As Per 2023 financial reports, 8 employees are currently employed by Bhavyas Pharmaceuticals Private Limited.
What change has been observed in the net worth of Bhavyas Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Bhavyas Pharmaceuticals Private Limited has experienced an upsurge of 2335.97%.
What are the total open charges for Bhavyas Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Bhavyas Pharmaceuticals Private Limited amount to ₹ 1.14 Cr.
When was the last Balance Sheet of Bhavyas Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Bhavyas Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records